Mochida Pharmaceutical (4534) Earnings: Operating Income Up 38.5% YoY to 3.56 Billion Yen, Net Income Jumps 67.8%

Mochida Pharmaceutical (4534) has released its financial results, reporting net sales of 31,719 million yen (a 19.1% increase year-on-year), operating income of 3,564 million yen (a 38.5% increase), ordinary income of 4,187 million yen (a 50.5% increase), and net income attributable to owners of the parent of 3,178 million yen (a 67.8% increase). The top-line expansion, driven by steady performance in the core pharmaceutical business, contributed significantly to the substantial profit growth across all income categories.

In terms of financial metrics, the company reports an ROE of 6.22% and an ROA of 4.33%, with EBITDA reaching 10.15 billion yen. Cash and cash equivalents are secured at 31.06 billion yen. Although operating cash flow was -7.35 billion yen and free cash flow was -24.20 billion yen, the company maintains its operational foundation supported by abundant liquidity.